FDA Inspection 1234890 — Sanofi S.R.L.
The FDA completed an inspection of Sanofi S.R.L. on Jun 21, 2024 in Anagni. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Anagni (Italy)